April 28, 2022
bioAffinity Technologies Presents CyPath® Lung advancements at the Cleveland Clinic Symposium Advancing Early Lung Cancer Detection
Chief Medical and Science Officer and Executive Vice President Vivienne Rebel, MD, PhD, will present at the Cleveland Clinic’s Advancing Early Lung Cancer Detection, an invitation-only symposium that brings together clinical experts, advocacy groups and industry leaders working to advance new technologies and methods necessary to find lung cancer at its earliest stages. The Symposium seeks to accelerate the development and implementation of tools to assist with the early detection of lung cancer. This is the third Symposium at which bioAffinity has been invited to present before the nation’s top clinical experts and advocacy groups who are interested in innovations addressing a shared goal of finding lung cancer at its earliest stages when treatment is most effective.
